ONCY

#3924
Oncolytics Biotech, Inc. Common Shares
1.02 USD
-2.86%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.02
1.02
Rango anual
0.33
1.51
Cambio diario
-2.86%
Variación mensual
+3.03%
Variación en los últimos 6 meses
-15.00%
Cambio anual
+72.88%
Cierres anteriores
1.05
Abrir
1.02
Bid
Ask
Mínimo
1.02
High
1.02
Volumen
11
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 118.45 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.91
Relación precio/flujo de caja
-169.59

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Noticias